Seeking Alpha As a reminder, M402 is our heparan sulfate mimetic engineered to optimize heparin's natural antitumor effects while reducing its anticoagulation activity to allow for higher doses. We are nearing the end of our Part A study for M402 in metastatic ... and more »
Seeking Alpha Heparin is a critical life-saving drug that we are very pleased to be able to provide to our customers. We don't include shortages in our financial proje...
Zacks.com Alongside, on Apr 17, American Capital sold SPL Acquisition Corp. to Shenzhen Hepalink Pharmaceutical Co., Ltd., one of the major suppliers of heparin sodium in the global market. As private equity markets continue to rebound, we look forward to ... and more »
Business Wire (press release) The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be ... and more »
DigitalJournal.com Research and Development Forecast of China Heparin Industry to 2017 mainly analyzes the global and domestic market status quo of heparin industry, development conditions of heparin upstream and downstream industry, the supply and demand of major ... and more »
Pharmacy Times Heparin -induced thrombocytopenia (HIT) is a well-described adverse drug reaction that can occur with heparin administration and lead to devastating thromboembolic complications.1 HIT is the most frequent drug-induced type of thrombocytopenia and is ...
TCTMD In patients undergoing percutaneous coronary intervention (PCI) for either non-ST-segment elevation acute coronary syndromes (NSTE-ACS) or stable ischemic heart disease, bivalirudin is associated with less bleeding compared with unfractionated heparin ...